Magnitude of the placebo effect in randomized trials of antiepileptic agents

Epilepsy and Behavior

Volumn 3, Issue 6, 2002, Pages 532-534

  Burneo, Jorge G ^a   Montori, Victor M ^b   Faught, Edward ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Antiepileptic agents; Epilepsy; Placebo; Randomized trials

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PLACEBO; TOPIRAMATE; ZONISAMIDE;

ADD ON THERAPY; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; EPILEPSY; EXPERIENCE; HUMAN; META ANALYSIS; MORBIDITY; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; REVIEW; TREATMENT OUTCOME;

EID: 0038823449     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-5050(02)00531-0     Document Type: Article

References (22)

1. Parsons HM. What happened at Hawthorne? Science 1974;183:922-32.
2. JM de Craen A, Tijssen JGP, de Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 2000;247:183-8.
3. Joyce DP, Jackevicus C, Chapman KR, et al. The placebo effect in asthma drug thrapy trials: a meta-analysis. J Asthma 37(4):303-18.
4. Keck PE, Welge JA, Strakowski SM, et al. Placebo effect in randomized, controlled maintenance studies of patients with bipolar disorder. Biol Psychiatry 2000;47:756-61.
5. Smith JL. Placebos in clinical trials of peptic ulcer. ACG committee on FDA-related matters. Am J Gastroenterol 1989;84:469-74.
6. Shetty N, Friedman JH, Kieburtz K, et al. The placebo response in Parkinson's disease. Clin Neuropharmacol 1999;22(4):207-12.
7. The Cochrane Database of Systematic Reviews. Available at: www.cochranelibrary.com. Accessed January 25, 2002.
8. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. Gabapentin add-on for drug-resistant partial epilepsy (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
9. Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2001.
10. Ramaratman S, Marson AG, Baker GA. Lamotrigine add-on for drug-resistant partial epilepsy (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 2001.
11. Jette NJ, Marson AG, Kadir ZA, Hutton JL. Topiramate add-on for drug-resistant partial epilepsy (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2001.
12. Castillo S, Schmidt DB, White S. Oxcarbazepine add-on for drug-resistant partial epilepsy (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2001.
13. Chaisewikul R, Privitera MD, Hutton JL, Marson AG. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2001.
14. Schierhout G, Roberts I. Antiepileptic drugs for preventing seizures following acute traumatic brain injury (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
15. Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick DW; on behalf of the epilepsy monotherapy trials. Carbamazepine versus valproate monotherapy for epilepsy (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software, 2001.
16. Hrobjartsson A, Gotzsche P. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344(21):1594-602.
17. Shapiro AK. A historic and heuristic definition of the placebo. Psychiatry 1964;27:52-8.
18. de Craen AJM, Kaptchuk TJ, Tijssen JGP, Kleijnen J. Placebos and placebo effects in medicine: historical overview. J R Soc Med 1999;92:511-5.
19. Turner JA, Deyo RA, Loeser JD, et al. The importance of placebo effects in pain treatment and research. JAMA 1994;271:1609-14.
20. Buckalew LW, Ross S, Starr BJ. Nonspecific factors in drug effects: placebo personality. Psychol Rep 1981;48:3-8.
21. Djulbegovic B. Placebo-controlled trials. Ann Intern Med 2001;135(1):62-4.
22. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects C29. Available at: www.wma.net. Accessed January 24, 2002.